Bayesian designs and the control of frequentist characteristics: a practical solution

DOI10.1111/BIOM.12226MaRDI QIDQ3465748zbMATH OpenOpenAlexWikidataFDO

Authors Steffen Ventz, Lorenzo Trippa

Publication date 22 January 2016

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1111/biom.12226

zbMATH Keywords

clinical trialsdecision theoryBayesian designfrequentist constraints

Mathematics Subject Classification ID

Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Bayesian problems; characterization of Bayes procedures (62C10)

Recommendations

• Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
• Bayesian designs with frequentist and Bayesian error rate considerations
• Control of type I error rates in Bayesian sequential designs
• Bayesian adaptive designs for clinical trials
• Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies

Cites work

• scientific article; zbMATH DE number 1085983 (Why is no real title available?)
• scientific article; zbMATH DE number 3229162 (Why is no real title available?)
• Approaches for Optimal Sequential Decision Analysis in Clinical Trials
• Bayesian Optimal Design for Phase II Screening Trials
• Bayesian adaptive methods for clinical trials
• Bayesian enrichment strategies for randomized discontinuation trials
• Bayesian randomized clinical trials: A decision-theoretic sequential design
• Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
• Doing What Comes Naturally: Interpreting a Tail Area as a Posterior Probability or as a Likelihood Ratio
• Early Stopping to Accept H 0 Based on Conditional Power: Approximations and Comparisons
• Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
• One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
• Reconciling Bayesian and Frequentist Evidence in the One-Sided Testing Problem
• Screening designs for drug development
• Sequential Trials, Sequential Analysis and the Likelihood Principle
• Simulation-based sequential Bayesian design
• Statistical monitoring of clinical trials. A unified approach.
• The relationship between the power prior and hierarchical models
• Why Isn't Everyone a Bayesian?

Cited in

(14)

• Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
• Control of type I error rates in Bayesian sequential designs
• Bayesian designs with frequentist and Bayesian error rate considerations
• Bayesian Response-Adaptive Designs for Basket Trials
• Bayesian uncertainty directed trial designs
• An Approximation Approach for Response-Adaptive Clinical Trial Design
• A dynamic power prior for Bayesian non-inferiority trials
• Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
• Frequentist test in Bayesian two-stage designs applied in experimental trials
• Frequentist operating characteristics of Bayesian optimal designs via simulation
• A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering
• Borrowing historical information for non-inferiority trials on Covid-19 vaccines
• Optimality of testing procedures for survival data in the nonproportional hazards setting
• Inference and Decision Making for 21st-Century Drug Development and Approval

Describes a project that uses

Uses Software

• R

This page was built for publication: Bayesian designs and the control of frequentist characteristics: a practical solution

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3465748)